Choreo, LLC Rani Therapeutics Holdings, Inc. Transaction History
Choreo, LLC
- $6.88 Billion
- Q4 2024
A detailed history of Choreo, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Choreo, LLC holds 11,813 shares of RANI stock, worth $18,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,813Holding current value
$18,073% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.09 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$755,1830.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$686,1920.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$463,1960.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$445,8120.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $37.5M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...